In Brief: Bristol’s Nivolumab Shows Survival, Boehringer Gains A Breakthrough & Sentinel Takes On Flu Vaccines, Plus CHMP Opinions

 
• By Emily Hayes
  

More from Clinical Trials

More from R&D